August
2000
|
Japan Science and Technology Agency, a pre-venture project, formed the Bone and Cartilage Regenerative Medicine Team (Professor Yukio Kato, Team Leader and Dr. Koichiro Tsuji, Sub-leader) in Hiroshima University Faculty of Dentistry. |
December
2002
|
We have received "Encouragement Award" at the 3rd Japanese BioBusiness Competition. |
April |
We have established TWO CELLS Co., Ltd. Established as a venture company, in Hiroshima University(Capital \10millon). Sub-leader, Dr. Koichiro Tsuji was assigned to be president and CEO. We have opened our head office at hiroshima, Japan. |
July
2003 |
Japan Science and Technology Agency pre-venture project completed. |
August
2003
|
We have started Research and development business. |
September
2003
|
We have funded by the president and his close associates as first capital investment. |
October
2003
|
We have received second capital infusions from SBIC (Small and medium Business Investment & Consultation) West Japan, SBIC East Japan, BML INC., Olympus Corp., HIROGIN Capital Co.,Ltd. |
February
2004
|
We have jointly investigated a Research Result Utilization Plaza sponsored by Science and Technology promotion Oraganization. |
October
2004
|
Conducted "Experiments for the Acquisition of Various Patent Rights" of Japan Science and Thechnology (JST). |
December
2004
|
TWO CELLS Co., Ltd. announced the appointment of Dr. Yukio Kato, Professor, Department of Dental and Medical Biochemistry, Graduate School of Biomedical Sciences, Hiroshima University, to Director. In his new position as Director, he will assume responsibility for the research and development function by a new system. |
May |
Entered into a licensing agreement with DENTSPLY International Inc.(USA). |
July
2005 |
Secured grants from Hiroshima City for new technologies industry-academia-govermment research and developments. |
July
2005 |
Signed a contract with Hiroshima University to conduct joint research on "Knowledge Clusters" |
December
2005
|
Appointed Prefessor Hidemi Kurihara, Graduate School of Biomedical Science, Hiroshima University, as Director of Clinical Research. |
April
2006 |
Tokyo Office has opened. |
June
2006 |
President Tsuji,
Directors Kato and Kurihara are awarded a special recognition
from Chugoku Region Conference. (Cluster Corporation Symposium
which is aimed for industry-government-university co-operation
in Chugoku region of Japan) Award name: Distinguished Service Medal to University-generated Venture Co. |
january
2007
|
3rd Additional Capital Infusion was made(Capital ¥125million). |
June 2007 |
Auditor changed. |
May 2008 |
Entered into a license agreement with DS Pharma Biomedical Co., Ltd to develop and commercialize STK2(Serum-free culture medium). DS Pharma Biomedical Co., Ltd launched the product STK2 on May 2008. |
April
2008 |
The organization was restructured.( Research and Development Division/ Sales Engineering Division/ Management Section) |
